secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2024-03-15T23:59:59+00:00
Accession:  0001493152-24-010089
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics appoints Richard Abbott as President effective March 15, 2024
----------------------------------------------------------------------------

- Richard Abbott, age 52, appointed President of Co-Diagnostics, effective March 15, 2024.
- He previously served as President of Advanced Conceptions, a wholly owned subsidiary acquired in December 2021.
- Through 50% ownership of Whiteknob LLC, he may earn up to 507,386 common shares and 166,503 warrants upon milestone achievements.
- Holds MBA from Wharton and MS/BS in Mechanical Engineering from Brigham Young University.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315224010089/0001493152-24-010089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315224010089/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-010089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer